Abdel-Magied AA, El-Kholya EI, Abou El-Khair SM, Abdelmegeed ES, Hamoudaa MM, Mohamed SA, El-Tantawy NL (2017) The genetic diversity of metronidazole susceptibility in Trichomonas vaginalis clinical isolates in an Egyptian population. Parasitol Res 116:3125-3130.
Al-Muzafar HM, Amin KA (2018) Thiazolidinedione induces a therapeutic effect on hepatosteatosis by regulating stearoyl-CoA desaturase-1, lipase activity, leptin and resistin. Exp Ther Med 16:2938-2948.
Amaravadi RK, Yu D, Lum JJ, Bui T, Christophorou MA, Evan GI, Thomas-Tikhonenko A, Thompson CB (2007) Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J Clin Investig 117:326–336.
APVMA (Australian Pesticides and Veterinary Medicines Authority) (2007) Final Review Report and Regulatory Decision: The Reconsideration of Registrations of Products Containing Dimetridazole and their Associated Approval Labels. Kingston, Australian Capital Territory, Australia:APVMA.Available: http://www.apvma.gov.au/products/review/docs/dimetridazole_final_report.pdf [accessed 31 May 2013].
Basaranoglu M, Neuschwander-Tetri BA (2006) Nonalcoholic fatty liver disease: clinical features and pathogenesis. Gastroenterol. Hepatol (NY) 2:282-291.
Cantelli-Forti G, Aicardi G, Guerra MC, Barbaro AM, Biagi GL (1983) Mutagenicity of a series of 25 nitroimidazoles and two nitrothiazoles in Salmonella typhimurium. Teratog Carcinog Mutagen 3:51-63.
Cavaliere A, Bacci M, Amorosi A, Del Gaudio M, Vitali R (1983) Induction of lung tumors and lymphomas in BALB/c mice by metronidazole. Tumori 69:379-382.
Cave MC, Clair HB, Hardesty JE, Falkner KC, Feng W, Clark BJ, Sidey J, Shi H, Aqel BA, McClain CJ, Prough RA (2016) Nuclear receptors and nonalcoholic fatty liver disease. Biochim Biophys Acta 1859:1083-1099.
Charrez B, Qiao L, Hebbard L (2016) Hepatocellular carcinoma and non-alcoholic steatohepatitis: The state of play. World J Gastroenterol 22:2494-2502.
Czaja MJ, Ding WX, Donohue TM Jr, Friedman SL, Kim JS, Komatsu M, Lemasters JJ, Lemoine A, Lin JD, Ou JH, Perlmutter DH, Randall G, Ray RB, Tsung A, Yin XM (2013) Functions of autophagy in normal and diseased liver. Autophagy 9:1131-1158.
Czarny P, Pawlowska E, Bialkowska-Warzecha J, Kaarniranta K, Blasiak J (2015) Autophagy in DNA damage response. Int J Mol Sci 16:2641-2662.
Drenick EJ, Fisler J, Johnson D (1982) Hepatic steatosis after intestinal bypass--prevention and reversal by metronidazole, irrespective of protein-calorie malnutrition. Gastroenterology 82:535-548.
EU (European Union) (2010) Commission Regulation (No 37/2010) on Pharmacologically Active Substances and their Classification Regarding Maximum Residue Limits in Foodstuffs of Animal Origin. Brussels:Off J Eur Union.Available: http://ec.europa.eu/health/files/eudralex/vol-5/reg_2010_37/reg_2010_37_en.pdf [accessed 31 May 2013].
Fahrig R, Engelke M (1997) Reinvestigation of in vivo genotoxicity studies in man. I. No induction of DNA strand breaks in peripheral lymphocytes after metronidazole therapy. Mutat Res 395:215-221.
Foley J, Ton T, Maronpot R, Butterworth B, Goldsworthy TL (1993) Comparison of proliferating cell nuclear antigen to tritiated thymidine as a marker of proliferating hepatocytes in rats. Environ Health Perspect 101 Suppl 5:199-205.
Freeman CD, Klutman NE, Lamp KC (1997) Metronidazole. A therapeutic review and update. Drugs 54:679-708.
Galati S, Boni C, Gerra MC, Lazzaretti M, Buschini A (2019) Autophagy: A Player in response to oxidative stress and DNA damage. Oxid Med Cell Longev 2019:5692958.
González-Rodríguez A, Mayoral R, Agra N, Valdecantos MP, Pardo V, Miquilena-Colina ME, Vargas-Castrillón J, Lo Iacono O, Corazzari M, Fimia GM, Piacentini M, Muntané J, Boscá L, García-Monzón C, Martín-Sanz P, Valverde ÁM (2014) Impaired autophagic flux is associated with increased endoplasmic reticulum stress during the development of NAFLD. Cell Death Dis 5:e1179.
Griffin MJ, Sul HS (2004) Insulin regulation of fatty acid synthase gene transcription: roles of USF and SREBP-1c. IUBMB Life 56:595-600.
Hall AP, Elcombe CR, Foster JR, Harada T, Kaufmann W, Knippel A, Küttler K, Malarkey DE, Maronpot RR, Nishikawa A, Nolte T, Schulte A, Strauss V, York MJ (2012) Liver hypertrophy: a review of adaptive (adverse and non-adverse) changes--conclusions from the 3rd International ESTP Expert Workshop. Toxicol Pathol 40:971-994.
Hanafi MY, Zaher ELM, El-Adely SEM, Sakr A, Ghobashi AHM, Hemly MH, Kazem AH, Kamel MA (2018) The therapeutic effects of bee venom on some metabolic and antioxidant parameters associated with HFD-induced non-alcoholic fatty liver in rats. Exp Ther Med 15:5091-5099.
IARC (1987) IARC Monographs on the evaluation of carcinogenic risks to humans, Supplement 7, Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs Volumes 1 to 42, IARC, Lyon.
Igarashi H, Maeda S, Ohno K, Horigome A, Odamaki T, Tsujimoto H (2014) Effect of oral administration of metronidazole or prednisolone on fecal microbiota in dogs. PLoS One 9: e107909.
Ito N, Tamano S, Shirai T (2003) A medium-term rat liver bioassay for rapid in vivo detection of carcinogenic potential of chemicals. Cancer Sci 94:3-8.
Jo HK, Kim GW, Jeong KJ, Kim DY, Chung SH (2014) Eugenol ameliorates hepatic steatosis and fibrosis by down-regulating SREBP1 gene expression via AMPK-mTOR-p70S6K signaling pathway. Biol Pharm Bull 37:1341-1351.
Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ (2005) Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease, Hepatology 41:1313-1321.
Kobori M, Masumoto S, Akimoto Y, Oike H (2011) Chronic dietary intake of quercetin alleviates hepatic fat accumulation associated with consumption of a Western-style diet in C57/BL6J mice. Mol Nutr Food Res 55:530-540.
Lavallard VJ, Gual P (2014) Autophagy and non-alcoholic fatty liver disease. Biomed Res Int 2014:120179.
Leitsch D (2017) Drug susceptibility testing in microaerophilic parasites: Cysteine strongly affects the effectivities of metronidazole and auranofin, a novel and promising antimicrobial. Int J Parasitol Drugs Drug Resist 7:321-327.
Leung HW, Jin L, Wei S, Tsui MM, Zhou B, Jiao L, Cheung PC, Chun YK, Murphy MB, Lam PK (2013) Pharmaceuticals in tap water: human health risk assessment and proposed monitoring framework in China. Environ Health Perspect 121:839-846.
Levy JR, Clore JN, Stevens W (2004) Dietary n-3 polyunsaturated fatty acids decrease hepatic triglycerides in Fischer 344 rats. Hepatology 39:608-616.
Ligha AE, Paul CW (2011) Oxidative effect of metronidazole on the testes of Wistar rats. Aust J Basic Appl Sci 5:1339-1344.
Marotta F, Barreto R, Wu CC, Naito Y, Gelosa F, Lorenzetti A, Yoshioka M, Fesce E (2005) Experimental acute alcohol pancreatitis-related liver damage and endotoxemia: synbiotics but not metronidazole have a protective effect. Chin J Dig Dis 6:193-197.
Masuda S, Mizukami S, Eguchi A, Ichikawa R, Nakamura M, Nakamura K, Okada R, Tanaka T, Shibutani M, Yoshida T (2019) Immunohistochemical expression of autophagosome markers LC3 and p62 in preneoplastic liver foci in high fat diet-fed rats. J Toxicol Sci 44:565-574.
Matsuda Y, Wakai T, Kubota M, Osawa M, Takamura M, Yamagiwa S, Aoyagi Y, Sanpei A, Fujimaki S (2013) DNA damage sensor γ -H2AX is increased in preneoplastic lesions of hepatocellular carcinoma. Sci World J 2013:597095.
Menéndez D, Rojas E, Herrera LA. López MC, Sordo M, Elizondo, G, Ostrosky-Wegman P (2001) DNA breakage due to metronidazole treatment. Mutat Res 478:153-158.
Mitsuyoshi H, Yasui K, Harano Y, Endo M, Tsuji K, Minami M, Itoh Y, Okanoue T, Yoshikawa T (2009) Analysis of hepatic genes involved in the metabolism of fatty acids and iron in nonalcoholic fatty liver disease. Hepatol Res 39:366-373.
Mizushima N, Komatsu M (2011) Autophagy: renovation of cells and tissues. Cell 147:728-741.
Mizushima N, Yoshimori T, Levine B (2010) Methods in mammalian autophagy research. Cell 140:313-326.
Mohn GR, Ong TM, Callen DF, Kramers PG, Aaron CS (1979) Comparison of the genetic activity of 5-nitroimidazole derivatives in Escherichia coli, Neurospora crassa, Saccharomyces cerevisiae and Drosophila melanogaster. J Environ Pathol Toxicol 2:657-670.
Murayama H, Eguchi A, Nakamura M, Kawashima M, Nagahara R, Mizukami S, Kimura M, Makino E, Takahashi N, Ohtsuka R, Koyanagi M, Hayashi SM, Maronpot RR, Shibutani M, Yoshida T (2018) Spironolactone in combination with α-glycosyl Isoquercitrin prevents steatosis-related early hepatocarcinogenesis in rats through the observed NADPH oxidase modulation. Toxicol Pathol 46:530-539.
Nseir W, Mahamid M (2013) Statins in nonalcoholic fatty liver disease and steatohepatitis: updated review. Curr Atheroscler Rep 15:305.
Obert LA, Sobocinski GP, Bobrowski WF, Metz AL, Rolsma MD, Altrogge DM, Dunstan RW (2007) An immunohistochemical approach to differentiate hepatic lipidosis from hepatic phospholipidosis in rats. Toxicol Pathol 35:728-734.
Palla VV, Karaolanis G, Katafigiotis I, Anastasiou I, Patapis P, Dimitroulis D, Perrea D (2017) gamma-H2AX: Can it be established as a classical cancer prognostic factor? Tumour Biol 39:1010428317695931.
Ré JL, De Méo MP, Laget M, Guiraud H, Castegnaro M, Vanelle P, Duménil G (1997) Evaluation of the genotoxic activity of metronidazole and dimetridazole in human lymphocytes by the comet assay. Mutat Res 375:147-155.
Reitz M, Rumpf M, Knitza R (1991) Metronidazole induces DNA strand-breaks in cultures of human lymphocytes and phytohemagglutinin-stimulated human lymphocytes. Arzneimittelforschung 41:65-69.
Rey S, Quintavalle C, Burmeister K, Calabrese D, Schlageter M, Quagliata L, Cathomas G, Diebold J, Molinolo A, Heim MH, Terracciano LM, Matter MS (2017) Liver damage and senescence increases in patients developing hepatocellular carcinoma. J Gastroenterol Hepatol 32:1480-1486.
Rottiers V, Näär AM (2012) MicroRNAs in metabolism and metabolic disorders. Nat Rev Mol Cell Biol 13:239-250.
Rustia M, Shubik P (1979) Experimental induction of hepatomas, mammary tumors, and other tumors with metronidazole in noninbred Sas:MRC(WI)BR rats. J Natl Cancer Inst 63:863-868.
Sanchez-Lazo L, Brisard D, Elis S, Maillard V, Uzbekov R, Labas V, Desmarchais A, Papillier P, Monget P, Uzbekova S (2014) Fatty acid synthesis and oxidation in cumulus cells support oocyte maturation in bovine. Mol Endocrinol 28:1502-1521.
Shamkhani K, Azarpira M, Akbar MH (2003) An open label crossover trial of effects of metronidazol on hyperlipidaemia. Int. J Cardiol 90:141-145.
Singh R, Kaushik S, Wang Y, Xiang Y, Novak I, Komatsu M, Tanaka K, Cuervo AM, Czaja MJ (2009) Autophagy regulates lipid metabolism. Nature 458:1131-1135.
Sisson G, Jeong JY, Goodwin A, Bryden L, Rossler N, Lim-Morrison S, Raudonikiene A, Berg DE, Hoffman PS (2000) Metronidazole activation is mutagenic and causes DNA fragmentation in Helicobacter pylori and in Escherichia coli containing a cloned H. pylori RdxA(+) (Nitroreductase) gene. J Bacteriol 182:5091-5096.
Starley BQ, Calcagno CJ, Harrison SA (2010) Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology 51:1820-1832.
Takahashi Y, Soejima Y, Fukusato T (2012) Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World J Gastroenterol 18:2300-2308.
Tanaka N, Aoyama T, Kimura S, Gonzalez FJ (2017) Targeting nuclear receptors for the treatment of fatty liver disease. Pharmacol Ther 179:142-157.
Wada T, Kenmochi H, Miyashita Y, Sasaki M, Ojima M, Sasahara M, Koya D, Tsuneki H, Sasaoka T (2010) Spironolactone improves glucose and lipid metabolism by ameliorating hepatic steatosis and inflammation and suppressing enhanced gluconeogenesis induced by high-fat and high-fructose diet. Endocrinology 151:2040-2049.
Wang W, Xu MJ, Cai Y, Zhou Z, Cao H, Mukhopadhyay P, Pacher P, Zheng S, Gonzalez FJ, Gao B (2017) Inflammation is independent of steatosis in a murine model of steatohepatitis. Hepatology 66:108-123.
Xiao H, Tong R, Ding C, Lv Z, Du C, Peng C, Cheng S, Xie H, Zhou L, Wu J, Zheng S (2015) γ-H2AX promotes hepatocellular carcinoma angiogenesis via EGFR/HIF-1α/VEGF pathways under hypoxic condition. Oncotarget 6:2180-2192.
Yamazaki Y, Kawarai S, Morita H, Kikusui T, Iriki A (2017) Faecal transplantation for the treatment of Clostridium difficile infection in a marmoset. BMC Vet Res 13:150.
Yu J, Shen B, Chu ES, Teoh N, Cheung KF, Wu CW, Wang S, Lam CN, Feng H, Zhao J, Cheng AS, To KF, Chan HL, Sung JJ (2010) Inhibitory role of peroxisome proliferator-activated receptor gamma in hepatocarcinogenesis in mice and in vitro. Hepatology 51:2008-2019.
Yoshida T, Murayama H, Kawashima M, Nagahara R, Kangawa Y, Mizukami S, Kimura M, Abe H, Hayashi SM, Shibutani M (2017) Apocynin and enzymatically modified isoquercitrin suppress the expression of a NADPH oxidase subunit p22phox in steatosis-related preneoplastic liver foci of rats. Exp Toxicol Pathol 69:9-16.
Zhang R, Kang KA, Piao MJ, Kim KC, Kim AD, Chae S, Park JS, Youn UJ, Hyun JW (2010) Cytoprotective effect of the fruits of Lycium chinense Miller against oxidative stress-induced hepatotoxicity. J Ethnopharmacol 130:299-306.
Zhang XJ, Chen S, Huang KX, Le WD (2013) Why should autophagic flux be assessed? Acta Pharmacol Sin 34:595-599.